ASCO 2019: Breakfast Brief – Head and neck cancer
PD DDr. Sacha Rothschild, University Hospital Basel, comments on this year’s head and neck cancer studies, as well as lung cancer trials.
More from this topic:
ASCO 2019: Durable responses in patients with melanoma brain metastases with nivolumab/ipilimumab
11. 06. 2019
ASCO 2019: Pembrolizumab facilitates previously unmet 5-year-overall survival for NSCLC
06. 06. 2019